Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

3.700

-0.015 (-0.40%)

At close: Sep 18, 2026, 4:00 PM EDT

3.710

+0.010 (0.27%)

After-hours: Sep 18, 2026, 7:30 PM EDT

Neuphoria Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	1.17	15.65	-	-	0.18
Other Revenue	-	-	-	-	3.99
Revenue	1.17	15.65	-	-	4.17
Revenue Growth	-92.50%	-	-	-	499.60%
Cost of Revenue	-	-	-	-	11.02
Gross Profit	1.17	15.65	-	-	-6.85
Selling, General & Admin	7.44	7.77	8.47	8.91	5.28
Research & Development	2.74	8.71	9.32	12.65	-
Other Operating Expenses	-	-	-	-	-0
Operating Expenses	10.18	16.48	17.8	21.56	5.27
Operating Income	-9.01	-0.83	-17.8	-21.56	-12.12
Interest Expense	-	-	-	-	-0.02
Interest & Investment Income	0.67	0.17	0.22	0.32	0.01
Currency Exchange Gain (Loss)	-0.54	-0.41	-0.21	0.31	0.25
Other Non Operating Income (Expenses)	-	-	-	-0.59	-2.59
EBT Excluding Unusual Items	-8.88	-1.08	-17.79	-21.52	-14.48
Merger & Restructuring Charges	-1.28	-	-	-	-
Impairment of Goodwill	-5.36	-	-	-	-
Gain (Loss) on Sale of Investments	1.93	0.24	2.21	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-0
Other Unusual Items	-	-	-	-	-0.65
Pretax Income	-13.59	-0.84	-15.58	-21.52	-15.12
Income Tax Expense	-0.14	-0.47	-0.09	-0.14	-0.13
Earnings From Continuing Operations	-13.45	-0.37	-15.49	-21.38	-14.99
Net Income	-13.45	-0.37	-15.49	-21.38	-14.99
Net Income to Common	-13.45	-0.37	-15.49	-21.38	-14.99
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	4	2	1	1,469	1,353
Shares Outstanding (Diluted)	4	2	1	1,469	1,353
Shares Change	170.85%	95.01%	-99.94%	8.53%	73.52%
EPS (Basic)	-3.06	-0.23	-18.62	-0.01	-0.01
EPS (Diluted)	-3.06	-0.23	-18.62	-0.01	-0.01
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-12.35	0.08	-14.68	-14.64	-14.99
Free Cash Flow Per Share	-2.81	0.05	-17.64	-0.01	-0.01
Gross Margin	100.00%	100.00%	-	-	-164.21%
Operating Margin	-767.32%	-5.30%	-	-	-290.62%
Profit Margin	-1145.66%	-2.36%	-	-	-359.34%
Free Cash Flow Margin	-1052.07%	0.49%	-	-	-359.30%
EBITDA	-8.35	-0.17	-17.13	-20.9	-11.49
EBITDA Margin	-	-1.06%	-	-	-275.36%
D&A For EBITDA	0.66	0.66	0.66	0.66	0.64
EBIT	-9.01	-0.83	-17.8	-21.56	-12.12
EBIT Margin	-	-5.30%	-	-	-290.62%
Revenue as Reported	1.17	15.65	-	-	-

SEC Filings: 10-K · 10-Q